Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease

Angioi A.;Lepori N.;Cabiddu G.;Pani A.
2023-01-01

Abstract

Sodium Zirconium Cyclosilicate (SZC) is commonly used for treating hyperkalemia because it sequesters gastrointestinal potassium ions, thereby reducing serum potassium levels. However, a less-discussed aspect of SZC is its radiopacity on x-ray-based imaging techniques. The European Medicines Agency (EMA) has only vaguely addressed this issue. Radiopaque substances like SZC can interfere with diagnostic imaging, creating challenges for clinicians and radiologists. We present the case of a 34-year-old Italian male to illustrate these concerns.
2023
Inglese
RENAL FAILURE
45
2
2284839
3
WOS:001108069500001
2-s2.0-85177472385
37982235
Esperti anonimi
internazionale
scientifica
Chronic Kidney Disease (CKD); Computed Tomography (CT) imaging; Diagnostic imaging; Hyperkalemia; Radiopacity; Sodium Zirconium Cyclosilicate
no
Angioi, A.; Floris, M.; Lepori, N.; Cabiddu, G.; Pani, A.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
open
Files in This Item:
File Size Format  
Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography a case of a patient with Hyperkalemia and kidney disease.pdf

open access

Type: versione editoriale
Size 1.31 MB
Format Adobe PDF
View/Open
1.31 MB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie